Cell-based immunotherapy is at the forefront of advanced cancer treatments. The most common cell-based immunotherapies to date are T-cell therapies. Cells being used for immunotherapy are commonly cultured in media supplemented with human serum. The use of serum introduces further variability into the process due to donor-to-donor variation, which leads to inconsistent cell growth and characteristics. Eliminating serum simplifies the process, lowers the regulatory risk, and reduces the associated logistical burden.
Nutri-T media eliminate this need for serum addition by substituting serum’s critical components with specific proteins, lipids, and other small molecules. Learn more about this xeno-free, serum-free media for the cultivation of lymphocytes.